Pascale Charbonnel holds a PhD in Molecular Microbiology Sciences from the Université de Paris XI – Orsay, France. She has been working in the Health Industry for 19 years both in animal and human health. From 2007 to 2012 she led animal vaccines development projects in R&D at Boehringer Ingelheim Animal Health France (Merial-legacy). She transitioned into a Key Accounts and Alliances Manager with Government and Public-Private vaccine manufacturers in Asia/Middle-East (S. Korea, Vietnam, Thailand, Egypt) a post she held for 6 years.
Being truly passionate about people and scientific innovation, she naturally evolved as a skilled business developer joining innovative equipment company, Ovizio, to develop business expansion towards new market applications (cell therapy and vaccine products) and added new territories in E-Asia. She recently joined the family of SCTbio to support business development activities.